Back to Search Start Over

The prolactin receptor scaffolds Janus kinase 2 via co-structure formation with phosphoinositide-4,5-bisphosphate.

Authors :
Araya-Secchi R
Bugge K
Seiffert P
Petry A
Haxholm GW
Lindorff-Larsen K
Pedersen SF
Arleth L
Kragelund BB
Source :
ELife [Elife] 2023 May 26; Vol. 12. Date of Electronic Publication: 2023 May 26.
Publication Year :
2023

Abstract

Class 1 cytokine receptors transmit signals through the membrane by a single transmembrane helix to an intrinsically disordered cytoplasmic domain that lacks kinase activity. While specific binding to phosphoinositides has been reported for the prolactin receptor (PRLR), the role of lipids in PRLR signaling is unclear. Using an integrative approach combining nuclear magnetic resonance spectroscopy, cellular signaling experiments, computational modeling, and simulation, we demonstrate co-structure formation of the disordered intracellular domain of the human PRLR, the membrane constituent phosphoinositide-4,5-bisphosphate (PI(4,5)P <subscript>2</subscript> ) and the FERM-SH2 domain of the Janus kinase 2 (JAK2). We find that the complex leads to accumulation of PI(4,5)P <subscript>2</subscript> at the transmembrane helix interface and that the mutation of residues identified to interact specifically with PI(4,5)P <subscript>2</subscript> negatively affects PRLR-mediated activation of signal transducer and activator of transcription 5 (STAT5). Facilitated by co-structure formation, the membrane-proximal disordered region arranges into an extended structure. We suggest that the co-structure formed between PRLR, JAK2, and PI(4,5)P <subscript>2</subscript> locks the juxtamembrane disordered domain of the PRLR in an extended structure, enabling signal relay from the extracellular to the intracellular domain upon ligand binding. We find that the co-structure exists in different states which we speculate could be relevant for turning signaling on and off. Similar co-structures may be relevant for other non-receptor tyrosine kinases and their receptors.<br />Competing Interests: RA, KB, PS, AP, GH, KL, SP, LA, BK No competing interests declared<br /> (© 2023, Araya-Secchi et al.)

Details

Language :
English
ISSN :
2050-084X
Volume :
12
Database :
MEDLINE
Journal :
ELife
Publication Type :
Academic Journal
Accession number :
37232489
Full Text :
https://doi.org/10.7554/eLife.84645